OakChart

InnovAge Holding Corp

INNVHealthcare·Medical Care Facilities·USA·Small·NASD·Nov 11 • 3:59 PM ET

9.50+0.13 (1.39%)
2026-11-12 05:26 CET
Market cap
1,296.34 USD m
Revenue, TTM
1,018.36 USD m
Net income, TTM
9.00 USD m
Free cash flow, TTM
76.31 USD m
EPS diluted, TTM
0.06
P/E
148.90
Compare

Price

INNV against its 20, 50 and 200-day averages
2050200beatmiss
6.008.0010.0012.003.3M6.6MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26INNVclose 9.5020-day 9.1850-day 9.56200-day 9.209.5052w high

24.8% under the 52-week high of 12.64 on 30 Jun 2026. 52-week low 4.70 on 9 Dec 2025. Last 15 sessions, 12.9% high to low

Volume 0.69× normal · the line is the 50-bar volume average

Profile

INNV
52-week range, 60% of the way up
4.7012.64

InnovAge Holding Corp. engages in managing the care of high-cost, frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). The firm's program is dedicated to enabling older adults to age independently in their own homes for as long as safely possible. It operates through the PACE and All Other segments. The company was founded in May 2007 and is headquartered in Denver, CO.

IndexRUT
Employees2500
IPOMar 04, 2021
Beta0.19
ATR, 14d0.46
Rel volume0.69
Short float2.80%
Insider own76.61%
Inst own14.71%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.30B
Enterprise Value1.25B
Income9.00M
Sales1.02B
Book/sh1.87
Cash/sh1.19
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees2500
IPOMar 04, 2021

Ratios

P/E148.90
Forward P/E18.29
PEG-
P/S1.27
P/B5.08
P/C7.95
P/FCF16.99
EV/EBITDA12.52
EV/Sales1.23
Quick Ratio1.16
Current Ratio1.16
Debt/Eq0.33
LT Debt/Eq0.28
Option/ShortYes / Yes

Earnings

EPS (ttm)0.06
EPS next Y0.52
EPS next Q0.10
EPS this Y2435.04%
EPS next Y11.23%
EPS next 5Y-
EPS past 3/5Y60.35% 43.49%
Sales past 3/5Y12.88% 9.19%
EPS Y/Y TTM151.01%
Sales Y/Y TTM15.11%
EPS Q/Q143.34%
Sales Q/Q12.14%
EarningsNov 03 AMC
EPS/Sales Surpr.62.98% 2.93%

Ownership

Insider Own76.61%
Insider Trans-19.00%
Inst Own14.71%
Inst Trans2.05%
ROA1.68%
ROE3.60%
ROIC2.76%
Gross Margin21.43%
Oper. Margin7.68%
Profit Margin0.88%
SMA203.44%
SMA50-0.67%
SMA2003.29%
Trades-

Technical

Shs Outstand136.46M
Shs Float31.91M
Short Float2.80%
Short Ratio1.59
Short Interest0.89M
52W High12.64 -24.84%
52W Low4.70 102.13%
Volatility5.85% 4.55%
ATR (14)0.46
RSI (14)53.69
Beta0.19
Rel Volume0.69
Avg Volume560.74K
Volume385,532

Performance

Perf Week-2.96%
Perf Month5.32%
Perf Quarter-10.80%
Perf Half Y28.55%
Perf YTD83.04%
Perf Year75.28%
Perf 3Y71.17%
Perf 5Y15.01%
Perf 10Y-
Recom3.00
Target Price12.00
Prev Close9.37
Price9.50
Change %1.39%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Aug 21, 2026UpgradeKKeyBanc Capital MarketsSector Weight → Overweight$13+36.8%
Sep 18, 2025ResumedJJP MorganUnderweight$5-47.4%
Dec 17, 2024DowngradeJJP MorganNeutral → Underweight$5-47.4%
Oct 11, 2024InitiatedKKeyBanc Capital MarketsSector Weight
May 16, 2022DowngradeRRobert W. BairdOutperform → Neutral$6 → $5-47.4%
Apr 20, 2022DowngradePPiper SandlerNeutral → Underweight$4 → $5-47.4%
Jan 10, 2022ResumedCCitigroupNeutral$8 → $5-47.4%
Dec 28, 2021DowngradeGGoldmanBuy → Neutral$15 → $4-57.9%
Dec 27, 2021DowngradeBBarclaysOverweight → Equal Weight$22 → $6.50-31.6%
Dec 23, 2021DowngradePPiper SandlerOverweight → Neutral$14 → $4-57.9%

Peers

Mkt cap
TickerCompanyMkt cap
ADUSAddus HomeCare Corp2.34B
AGLAgilon Health Inc1.93B
ASTHAstrana Health Inc1.63B
BKDBrookdale Senior Living Inc2.21B
NHCNational Healthcare Corp3.30B
PNTGPennant Group Inc1.29B
ALHCAlignment Healthcare Inc1.61B
ENSGEnsign Group Inc10.86B
CLOVClover Health Investments Corp2.64B
MOHMolina Healthcare Inc10.92B

Insider trading

10 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
DAMATO NICOLECHIEF LEGAL OFFICEROct 22 '26Sale9.513,40232,353301,495Oct 26 04:03 PM
Welsh, Carson, Anderson & Stow10% OwnerOct 21 '26Sale9.251,500,00013,875,000101,076,555Oct 23 04:30 PM
IGNITE AGGREGATOR LP10% OwnerOct 21 '26Sale9.251,500,00013,875,000101,076,555Oct 23 04:05 PM
TCO GROUP HOLDINGS, L.P.10% OwnerOct 21 '26Sale9.251,500,00013,875,000101,076,555Oct 23 04:05 PM
DAMATO NICOLECHIEF LEGAL OFFICERSep 25 '26Sale8.7023,814207,182304,897Sep 29 04:04 PM
TCO GROUP HOLDINGS, L.P.10% OwnerSep 24 '26Sale9.2510,000,00092,500,000102,576,555Sep 28 04:15 PM
IGNITE AGGREGATOR LP10% OwnerSep 24 '26Sale9.2510,000,00092,500,000102,576,555Sep 28 04:15 PM
Nicole DamatoAffiliateSep 25 '26Proposed Sale8.6034,021292,581Sep 25 04:08 PM
SCARBROUGH MICHAEL ANTHONYPresident and COONov 14 '25Sale4.9033,000161,700119,617Nov 17 04:39 PM
SCARBROUGH MICHAEL ANTHONYOfficerNov 14 '25Proposed Sale5.1333,000169,250Nov 14 03:35 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
FSCCFederated Hermes MDT Small Cap Core ETFAUM: 494.86M
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
VFMFVanguard U.S. Multifactor ETFAUM: 1.16B
DFMCU.S. Micro Cap Portfolio ETF Class SharesAUM: 212.10M

News

latest 14 of 200
  • InnovAge Beats Handily On Record-Level Margins, But A Merely Reaffirmed Guide Keeps The Rest Of Fiscal 2027 In Question (Earnings Whispers) +10.62%
  • InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2026 (GlobeNewswire)
  • InnovAge Opens Fiscal 2027 With Street Revenue Bar Set Below Its Own Guidance (Earnings Whispers)
  • InnovAge to Announce Fiscal First Quarter 2027 Financial Results and Host Conference Call Tuesday, November 3, 2026 (GlobeNewswire)
  • InnovAge Announces Pricing of Secondary Offering of Common Stock by Selling Stockholders (GlobeNewswire) -15.53%
  • InnovAge Announces Launch of Proposed Secondary Offering of Common Stock by Selling Stockholders (GlobeNewswire)
  • InnovAge Holding Corp (INNV) (Q4 2026) Earnings Call Highlights: Strong EBITDA Growth and ... (GuruFocus.com)
  • InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2026 (GlobeNewswire)
  • InnovAge Announces Conference Call to Discuss Fourth Quarter and Fiscal 2026 Financial Results and Participation in Upcoming Wells Fargo Healthcare Conference (GlobeNewswire)
  • InnovAge Appoints Jennifer Browne as President and Chief Operating Officer (GlobeNewswire)
  • InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2026 (GlobeNewswire)
  • Earnings To Watch: InnovAge Holding Corp (INNV) Reports Q3 2026 Result (GuruFocus.com)
  • InnovAge to Announce Fiscal Third Quarter 2026 Financial Results and Host Conference Call Tuesday, May 5, 2026 (GlobeNewswire)
  • Is Community Health Systems Attractive Despite Its Heavy Debt Load? (Zacks)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2027Q12026-11-030.1400.0860.140264.76257.233
2026Q42026-09-080.0600.0750.060261.95238.333
2026Q32026-05-05-0.2200.055-0.217251.94234.343
2026Q22026-02-030.0800.0410.078239.71228.363
2026Q12025-11-040.0600.0220.059236.11226.53
2025Q42025-09-09-0.010-0.014-0.006221.42219.724
2025Q32025-05-06-0.080-0.011-0.084218.14214.124
2025Q22025-02-04-0.100-0.012-0.098209210.184
2025Q12024-11-05-0.040-0.038-0.036205.14203.334
2024Q42024-09-10-0.010-0.020-0.013199.4191.434
2024Q32024-05-07-0.040-0.035-0.043193.07188.164
2024Q22024-02-06-0.030-0.031-0.025188.9183.924
2024Q12023-11-07-0.080-0.037-0.076182.49177.894
2023Q42023-09-12-0.090-0.035-0.082176.87175.774
2023Q32023-05-09-0.050-0.047-0.049172.54174.144
2023Q22023-02-07-0.070-0.083-0.072167.46169.755

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2021FY-0.360-0.240-0.325637.8633.89
2022FY-0.0500.057-0.048698.64698.95
2023FY-0.300-0.260-0.300688.09686.11
2024FY-0.160-0.173-0.157763.86756.16
2025FY-0.220-0.174-0.224853.7852.01
2026FY-0.020-0.009-0.019989.71966.04
2027FY-0.467--1,077
2028FY-0.520--1,163

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2027Q2S2026-11-04320262.53260264
2027Q2S2026-11-03320262.5260265.31
2027Q2S2026-11-02320262.5260265.31
2027Q2S2026-09-14330262.5260265.31
2027Q2S2026-09-09220263.75262.2265.31
2027Q2S2026-08-19310256.5253261.8
2027Q2S2026-05-28300254.4253255.5
2027Q2S2026-05-06300254.74254255.5
2027Q2S2026-04-20200255.06254256.13
2027Q2S2026-04-08210255.06254256.13
2027Q2S2026-02-19220255.06254256.13
2027Q2S2026-02-04110256.13256.13256.13
2027Q2S2025-12-25100249.06249.06249.06
2027Q2S2025-11-24200248.53248249.06

Estimate history

EPS, annual0.1470.197-0.325-0.048-0.3-0.157-0.224-0.0190.0638
Period20192020202120222023202420252026TTM
EPS, quarterly-0.036-0.098-0.084-0.0060.0590.078-0.2170.060.143
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Sales, annual465.63567.192637.8698.64688.087763.855853.699989.7071018.36
Period20192020202120222023202420252026TTM
Sales, quarterly205.142208.999218.142221.417236.105239.708251.943261.951264.757
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Shares, annual133.187133.187135.517135.533135.64136.116135.44136.02136.457
Period20192020202120222023202420252026MRQ
Shares, quarterly135.539135.349135.078135.44135.681135.699135.711136.02136.457
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Income statement, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue1,018.36989.71853.70763.86688.09698.64637.80567.19465.63
Cost of Goods Sold Incl. D&A800.08783.09719.57650.74602.22577.19476.01437.18364.00
Gross Profit218.28206.62134.13113.1185.87121.45161.79130.01101.63
Selling, General and Administrative Excl. Other140.07140.34127.05130.34124.35123.6886.9677.4864.71
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income78.2166.287.08-17.22-38.48-2.2374.8252.5336.92
Interest Expense3.134.264.614.021.522.5316.7914.629.59
Unusual Expense63.7363.6639.447.9610.922.1789.420.003.14
Net Income Before Taxes12.390.27-34.03-21.82-50.79-7.24-34.9735.6325.39
Income Taxes-0.140.951.321.40-7.240.729.779.876.32
Consolidated Net Income12.53-0.68-35.34-23.22-43.55-7.96-44.7425.7719.07
Net Income From Continuing Operations9.00-2.54-30.31-21.34-40.67-6.52-43.9926.2819.58
Net Income9.00-2.54-30.31-21.34-40.67-6.52-43.9926.2819.58
EPS (Recurring)0.390.31-0.02-0.12-0.24-0.040.140.200.16
EPS (Basic, Before Extraordinaries)0.07-0.02-0.22-0.16-0.30-0.05-0.320.200.15
EPS (Diluted)0.06-0.02-0.22-0.16-0.30-0.05-0.320.200.15
EBITDA99.9287.4226.591.73-18.4611.6987.1263.8245.92
Non-Operating Income (Expense)1.041.912.957.380.12-0.30-3.58-2.281.20
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense5.125.576.025.403.942.9534.350.400.53
Price To Earnings Ratio148.90148.90-------
Price To Sales Ratio1.181.620.590.881.480.854.53--
Gross Margin21.4320.8815.7114.8112.4817.3825.3722.9221.83
Operating Margin7.686.700.83-2.25-5.59-0.3211.739.267.93
Net Margin0.88-0.26-3.55-2.79-5.91-0.93-6.904.634.20
Shares Outstanding136.46136.02135.44136.12135.64135.53135.52133.19133.19
Market Capitalization1,296.341,296.34498.20674.501,017.23593.602,887.872,829.59-

Income statement, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q42025Q32025Q2
Total Revenue264.76261.95251.94239.71236.10221.42218.14209.00
Cost of Goods Sold Incl. D&A206.83205.75195.75191.76189.83183.52182.78177.25
Gross Profit57.9356.2156.2047.9546.2737.8935.3631.75
Selling, General and Administrative Excl. Other35.7540.1632.3131.8536.0230.9232.0433.13
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income22.1816.0523.8816.1010.256.973.32-1.38
Interest Expense0.120.770.991.251.250.891.160.76
Unusual Expense2.035.9052.962.841.869.1213.4811.18
Net Income Before Taxes20.049.67-29.7712.467.92-4.20-11.06-13.46
Income Taxes-0.84-0.120.170.650.250.810.070.03
Consolidated Net Income20.889.78-29.9411.807.67-5.01-11.13-13.49
Net Income From Continuing Operations19.558.29-29.4610.628.02-0.79-11.38-13.22
Net Income19.558.29-29.4610.628.02-0.79-11.38-13.22
EPS (Recurring)0.150.090.060.090.070.04-0.01-0.04
EPS (Basic, Before Extraordinaries)0.140.06-0.220.080.06-0.01-0.08-0.10
EPS (Diluted)0.140.06-0.220.080.06-0.01-0.08-0.10
EBITDA27.8422.4028.7020.9815.3410.378.713.94
Non-Operating Income (Expense)0.010.290.290.440.77-1.160.26-0.14
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.381.371.410.961.821.221.611.48
Price To Earnings Ratio148.90-172.47-----
Price To Sales Ratio1.181.641.150.770.800.580.480.66
Gross Margin21.8821.4622.3120.0019.6017.1116.2115.19
Operating Margin8.386.139.486.724.343.151.52-0.66
Net Margin7.393.16-11.694.433.40-0.35-5.22-6.33
Shares Outstanding136.46136.02135.71135.70135.68135.44135.08135.35
Market Capitalization1,296.341,608.471,088.31704.18699.89498.20403.03532.34

Balance sheet, annual

Currency USD, millions
Metric2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Cash & Short Term Investments141.34105.92102.79173.48184.45203.70114.5661.20
Short Term Receivables45.6739.6851.4324.6142.6737.9848.0555.01
Inventories0.000.000.000.000.000.000.000.00
Other Current Assets27.3130.5118.9217.1413.849.254.313.25
Total Current Assets214.31176.11173.14215.23240.96250.93166.93119.45
Net Property, Plant & Equipment187.50194.94221.44213.40176.26142.72102.49101.19
Total Investments and Advances0.000.002.655.495.493.4915.8915.43
Long-Term Note Receivable-2.202.80-----
Intangible Assets145.26145.92144.49129.41130.07130.74121.32123.11
Deferred Tax Assets31.6230.3832.1726.857.286.86--
Other Assets10.327.673.153.822.813.883.004.07
Total Assets589.01557.23579.84594.21562.87538.61409.63363.23
Short Term Debt Incl. Current Port. of LT Debt13.4012.1712.5412.057.165.873.433.63
Accounts Payable115.3676.7555.4654.9450.5632.3628.8830.35
Income Tax Payable--0.001.21----
Other Current Liabilities75.1375.8970.6080.2647.5840.3444.3249.48
Total Current Liabilities203.89164.81138.60148.45105.3178.5676.6383.46
Long Term Debt73.5588.92100.5096.7977.6576.76214.52191.15
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Deferred Tax Liabilities40.6739.1439.6333.0925.0422.569.286.11
Other Liabilities2.131.461.301.091.132.761.451.08
Total Liabilities320.24294.32280.03279.41209.13180.65301.88281.79
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity235.60234.97269.26296.30332.36334.56101.0274.19
Total Shareholders Equity235.60234.97269.26296.30332.36334.56101.0274.19
Accumulated Minority Interest33.1727.9430.5518.5021.3823.416.747.25
Total Equity268.78262.91299.81314.80353.74357.96107.7581.44
Total Liabilities & Stockholders Equity589.01557.23579.84594.21562.87538.61409.63363.23
Book Value Per Share1.731.731.982.182.452.470.760.56
Tangible Book Value Per Share0.660.660.921.231.491.50-0.15-0.37
Full-Time Employees2,5002,4402,3502,1002,0001,800--
Price to Book Ratio5.082.092.403.431.798.628.62-
Return on Assets-0.44-5.33-3.63-7.03-1.18-9.286.80-
Return on Equity-1.08-12.02-7.55-12.94-1.95-20.2030.00-
Return on Invested Capital-0.82-9.36-5.77-10.35-1.59-10.698.337.38
Quick Ratio1.051.071.251.452.293.192.181.43
Current Ratio1.051.071.251.452.293.192.181.43

Cash flow, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income12.53-0.68-35.34-23.22-43.55-7.96-44.7425.7719.07
Depreciation21.7121.1419.5118.9520.0213.9212.2911.299.00
Other Funds (Non Cash)20.5620.4832.1618.309.6510.6518.599.934.28
Funds from Operations54.0441.2317.6315.25-25.4018.68-7.4450.1635.90
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital35.4923.4815.23-52.1545.648.62-0.11-6.33-9.99
Income Taxes Payable--0.00-1.211.21----
Cash from Operating Activities89.5364.7132.87-36.9020.2427.30-7.5543.8325.91
Capital Expenditures-13.22-14.31-6.26-7.91-23.35-38.24-19.54-11.84-14.49
Net Assets From Acquisitions0.000.00-4.77-23.920.000.000.000.00-27.54
Sale of Fixed Assets and Businesses0.003.721.254.840.000.000.000.170.00
Purchase or Sale of Investments-1.73-1.754.240.61-46.17-2.000.00-1.15-10.45
Purchase of Investments-1.73-1.75-2.06-2.38-46.17-2.000.00-1.15-10.45
Sale Or Maturity of Investments0.000.006.303.000.000.000.00--
Other Uses-0.08-0.08-1.050.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.001.130.00
Cash from Investing Activities-15.03-12.42-6.60-26.37-69.52-40.24-19.54-11.69-52.48
Cash Dividends Paid0.000.000.000.000.000.00-9.500.00-66.51
Change in Capital Stock-2.001.57-7.322.720.000.00292.870.000.28
Repurchase of Common Pref Stock0.000.00-7.32-0.180.000.00-77.600.00-0.19
Sale of Common Pref Stock-2.001.570.002.900.000.00370.470.000.47
Proceedsfrom Stock Options-2.001.570.002.900.000.00370.470.000.47
Issuance or Reduction of Debt, Net-17.54-18.39-9.91-8.43-7.90-6.32-154.3421.23111.89
Change in Long Term Debt-17.54-18.39-9.91-8.43-7.90-6.32-154.3421.23111.89
Issuance of Long Term Debt-0.4258.090.000.000.000.00360.1025.00241.07
Reduction of Long Term Debt-17.12-76.49-9.91-8.43-7.90-6.32-514.45-3.77-129.19
Net Financing Active Other Cash Flow-2.94-1.70-1.85-1.320.000.00-12.800.00-8.31
Other Financing Activities Uses-2.94-1.70-1.85-1.320.000.00-32.800.00-8.31
Cash from Financing Activities-22.48-18.53-19.08-7.03-7.90-6.32116.2221.2337.35
Net Change in Cash52.1033.767.18-70.31-57.18-19.2589.1453.3710.77
Free Cash Flow76.3150.4126.60-44.81-3.12-10.94-25.0931.9811.42
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow15.8131.9018.78------
Deferred Taxes & Investment Tax Credit-0.291.301.22-11.532.066.423.173.55

Balance sheet, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q4
Cash & Short Term Investments163.00141.34138.60125.97109.43105.92
Short Term Receivables26.3445.6731.9724.6126.4839.68
Inventories0.000.000.000.000.000.00
Other Current Assets34.4427.3132.0531.2725.7930.51
Total Current Assets223.78214.31202.61181.85161.70176.11
Net Property, Plant & Equipment183.98187.50189.02189.35192.12194.94
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets145.10145.26145.43145.59145.76145.92
Deferred Tax Assets-31.62---30.38
Other Assets10.1010.3210.3310.6810.667.67
Total Assets562.96589.01547.39527.48510.23557.23
Short Term Debt Incl. Current Port. of LT Debt13.0413.4012.3412.3212.8012.17
Accounts Payable100.68115.36105.5955.9050.8076.75
Other Current Liabilities78.7675.1377.9676.4874.8975.89
Total Current Liabilities192.48203.89195.89144.70138.49164.81
Long Term Debt70.8973.5581.5183.0485.2888.92
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities8.2540.679.289.279.0139.14
Other Liabilities2.132.131.821.701.691.46
Total Liabilities273.75320.24288.50238.72234.47294.32
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity255.34235.60229.03256.79244.98234.97
Total Shareholders Equity255.34235.60229.03256.79244.98234.97
Accumulated Minority Interest33.8833.1729.8631.9830.7927.94
Total Equity289.22268.78258.89288.76275.77262.91
Total Liabilities & Stockholders Equity562.96589.01547.39527.48510.23557.23
Book Value Per Share1.871.731.691.891.811.73
Tangible Book Value Per Share0.810.660.620.820.730.66
Full-Time Employees-2,500---2,440
Price to Book Ratio5.087.024.242.872.972.09
Return on Assets1.68-0.44-2.141.23-3.35-5.33
Return on Equity3.60-1.08-4.972.56-6.86-12.02
Return on Invested Capital5.992.68-9.493.122.43-0.24
Quick Ratio1.161.051.031.261.171.07
Current Ratio1.161.051.031.261.171.07

Cash flow, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q4
Net Income20.889.78-29.9411.807.67-5.01
Depreciation5.666.364.824.885.083.39
Other Funds (Non Cash)4.388.373.973.844.3010.58
Funds from Operations30.1124.28-21.1320.7817.309.76
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-1.37-2.9939.270.58-13.38-0.76
Income Taxes Payable-----0.00
Cash from Operating Activities28.7421.2918.1421.363.929.00
Capital Expenditures-2.99-4.27-3.60-2.36-4.080.18
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.003.721.25
Purchase or Sale of Investments-0.44-0.55-0.20-0.54-0.45-0.46
Purchase of Investments-0.44-0.55-0.20-0.54-0.45-0.46
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.00-0.080.000.000.00-1.05
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-3.42-4.90-3.80-2.90-0.81-0.08
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-0.36-1.630.000.003.20-0.30
Repurchase of Common Pref Stock0.000.000.000.000.00-0.30
Sale of Common Pref Stock-0.36-1.630.000.003.200.00
Proceedsfrom Stock Options-0.36-1.630.000.003.200.00
Issuance or Reduction of Debt, Net-2.04-11.21-1.92-2.38-2.89-3.91
Change in Long Term Debt-2.04-11.21-1.92-2.38-2.89-3.91
Issuance of Long Term Debt0.000.000.00-0.4258.520.00
Reduction of Long Term Debt-2.04-11.21-1.92-1.95-61.41-3.91
Net Financing Active Other Cash Flow-1.56-1.27-0.08-0.03-0.32-1.04
Other Financing Activities Uses-1.56-1.27-0.08-0.03-0.32-1.04
Cash from Financing Activities-3.96-14.11-2.01-2.40-0.01-5.25
Exchange Rate Effect0.00-0.000.00-0.08-
Net Change in Cash21.362.3512.3316.063.023.67
Free Cash Flow25.7517.0214.5419.00-0.159.18
Price to Free Cash Flow15.8132.2525.5714.2219.5118.74

Revenue breakdown

Capitation revenue2025: 852.35M 2026: 988.38M
Other service revenue2025: 1.35M 2026: 1.32M
United States2025: 853.70M 2026: 989.71M
Other Segments2025: 990.00K 2026: 257.00K
Program of All-inclusive Care for the Eldery2025: 852.71M 2026: 989.45M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.80%0.9M31.9M520.59K
2026-10-153.59%1.1M31.9M459.36K
2026-09-308.50%2.7M31.4M419.93K
2026-09-155.51%1.2M21.3M318.77K
2026-08-314.94%1.0M20.8M329.03K
2026-08-144.19%0.9M20.8M338.22K
2026-07-313.89%0.8M20.8M356.23K
2026-07-154.77%1.0M21.0M344.87K
2026-06-305.31%1.1M21.0M335.33K
2026-06-153.62%0.8M21.2M293.20K
2026-05-295.39%1.2M21.4M293.58K
2026-05-154.70%1.0M21.4M306.36K
2026-04-303.95%0.8M21.4M344.77K
2026-04-153.28%0.7M21.4M330.93K
2026-03-312.71%0.6M21.2M302.14K
2026-03-131.57%0.3M21.2M266.02K
2026-02-271.28%0.3M21.2M232.58K
2026-02-131.23%0.3M21.2M214.20K
2026-01-301.88%0.4M21.2M169.41K
2026-01-151.31%0.3M21.2M161.81K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.506.107.607.149.43012.000.000.949-0.0920.002
call5.003.704.903.914.28453.000.000.880-0.0930.003
call7.501.552.302.501.89058.000.000.771-0.0760.004
call10.000.000.250.200.7072630.000.372-0.0300.006
call12.500.000.300.051.76515.000.000.195-0.0410.004
call15.000.000.750.002.4730.000.000.155-0.0480.004
call17.500.001.150.052.9842.000.000.136-0.0540.003
call20.000.000.950.003.4000.000.000.125-0.0570.003
call22.500.000.750.003.7510.000.000.116-0.0600.003
put2.500.001.150.0010.4150.000.00-0.051-0.0910.002
put5.000.000.750.005.4640.000.00-0.123-0.0910.003
put7.500.000.750.052.98210.000.00-0.229-0.0750.004
put10.000.001.451.411.9743.000.00-0.590-0.0330.006
put12.502.703.900.003.0860.000.00-0.805-0.0400.004
put15.005.106.600.004.2530.000.00-0.844-0.0470.004
put17.507.509.000.004.6860.000.00-0.864-0.0520.003
put20.0010.0011.500.005.1840.000.00-0.876-0.0560.003
put22.5012.1014.300.006.1740.000.00-0.884-0.0590.003

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-05SCHEDULE 13G/ASEC
2026-11-0310-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-038-KCurrent report2026-11-03SEC
2026-10-264Statement of changes in beneficial ownership of securities2026-10-22SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-21SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-21SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-21SEC
2026-10-22ARSAnnual report to security holders. 2026-06-30SEC
2026-10-22DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-10-22DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-12-03SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-24SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-24SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-24SEC
2026-09-25144Filing for proposed sale of securities under Rule 144.SEC
2026-09-248-KCurrent report2026-09-22SEC
2026-09-24424B4SEC
2026-09-22424B7SEC
2026-09-0910-KAnnual report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-09-088-KCurrent report2026-09-08SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-09-03SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-09-03SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-09-03SEC
2026-08-173Initial statement of beneficial ownership of securities2026-08-17SEC
2026-08-04EFFECTEffectiveness filing by commission orderSEC
2026-07-31S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-07-274Statement of changes in beneficial ownership of securities2026-07-27SEC
2026-07-234Statement of changes in beneficial ownership of securities2026-07-22SEC
2026-07-234Statement of changes in beneficial ownership of securities2026-07-22SEC
2026-07-234Statement of changes in beneficial ownership of securities2026-07-22SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100041.66M4
2026-0900185.21M3
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-1100161.70K1

Institutional holders

Manager% owned
T. Rowe Price Investment Management, Inc.4.51%
FEDERATED HERMES, INC.1.40%
BlackRock, Inc.1.10%
BARCLAYS PLC0.97%
VANGUARD CAPITAL MANAGEMENT LLC0.69%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP0.49%
ALGERT GLOBAL LLC0.46%
GEODE CAPITAL MANAGEMENT, LLC0.44%
STATE STREET CORP0.34%
DIMENSIONAL FUND ADVISORS LP0.33%

Funds

Fund% owned
T. Rowe Price Small-Cap Value Fund, Inc.2.47%
Federated Hermes MDT Small Cap Core Fund0.66%
VANGUARD TOTAL STOCK MARKET INDEX FUND0.49%
iShares Russell 2000 ETF0.43%
Bridge Builder Small/Mid Cap Growth Fund0.26%
Federated Hermes MDT Small Cap Growth Fund0.25%
VANGUARD EXTENDED MARKET INDEX FUND0.18%
Fidelity Small Cap Index Fund0.18%
Inspire Fidelis Multi Factor ETF0.16%
Small Cap Value Portfolio0.16%

OakChart. INNV. Cached 15 minutes.